FluoroPharma Medical, Inc. (OTCPK: FPMI)
Health Care · Biotechnology · US
$—
— today · — 1Y
FluoroPharma Medical, Inc. (OTCPK: FPMI) operates in the Biotechnology industry within the Health Care sector. The company is valued at $5.51K and employs 4 people.
trading between 0.00 and 0.00.
Tweenvest scores FluoroPharma Medical, Inc. across four factors: quality 17/100, value 52/100. Its strongest factor is value.
FPMI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.51K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.08
- Dividend yield
- —
- Beta (5Y)
- -109.71
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 27.58M
- Employees
- 4
- Next earnings
- —
About FluoroPharma Medical, Inc.
FluoroPharma Medical, Inc. (FPMI) is a biopharmaceutical firm dedicated to the discovery, development, and commercialization of advanced molecular imaging agents. Initially, its efforts are concentrated on cardiovascular applications within the United States market. The company's pipeline features two notable product candidates: BFPET: An imaging agent designed for stress-testing patients with suspected or confirmed coronary artery disease (CAD), which has successfully completed its Phase I clinical trial. CardioPET: Another molecular imaging agent, currently undergoing a Phase IIa clinical trial. This compound aims to evaluate myocardial blood flow and metabolism in individuals afflicted with CAD. FluoroPharma Medical has established key collaborations, including licensing agreements with Massachusetts General Hospital and Sinotau USA. Furthermore, the company holds clinical research agreements with Pharmaceutical Product Development, LLC, and Cardiovascular Imaging Technologies. Established in 2003, FluoroPharma Medical, Inc. is headquartered in Montclair, New Jersey.
- ISIN
- US3438701019
- Founded
- 2003
- Listed since
- May 16, 2011
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| IO Biotech, Inc.OTCPK: IOBT.Q | $7.20K | $0.00 | -50.00% |
| NovAccess Global Inc.OTCPK: XSNX | $6.17K | $0.00 | — |
| Theralink Technologies, Inc.OTCPK: THER | $6.15K | $0.00 | — |
| Scorpius Holdings, Inc.OTCPK: SCPX | $6.11K | $0.00 | -50.00% |
| Aridis Pharmaceuticals, Inc.OTCPK: ARDS | $5.33K | $0.00 | +9900.00% |
| MultiCell Technologies, Inc.OTCPK: MCET | $5.00K | $0.00 | — |
| Arno Therapeutics, Inc.OTCPK: ARNI | $4.98K | $— | — |
| Panbela Therapeutics, Inc.OTCPK: PBLA | $4.86K | $0.00 | -66.67% |
Figures last refreshed Oct 18, 2026.